ArticleAmerican journal of translational research2017
miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
Dengfeng Li et al.PubMed ↗Full text ↗
No numbers read from the abstract.
40 papers cite it
this papercites it